|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Biomedical Sciences Division of Cancer Biology (S.E.E) and Graduate Program in Pharmacology (Y.R.D.), Meharry Medical College, Nashville, Tennessee
The aryl hydrocarbon receptor (AhR) is a ligand-activated basic-helix-loop-helix transcription factor that binds polyaromatic hydrocarbons (PAH), such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), and mediates their toxicity. Binding of PAH to AhR in the cytoplasm triggers a poorly defined transformation step of the receptor into a nuclear transcription factor. In this study, we show that the calcium-dependent cysteine protease calpain plays a major role in the ligand-induced transformation and signaling of AhR. Fluorescence imaging measurements showed that TCDD treatment elevates intracellular calcium, providing the trigger for calpain activation, as measured toward t-butoxycarbonyl-Leu-Met-chloromethylaminocoumarin, a calpain-specific substrate. Inhibition of calpain activity by the N-benzyloxycarbonyl-Val-Phe-aldehyde (MDL28170) blocked the TCDD-induced nuclear translocation of AhR in Hepa1c1c7 mouse hepatoma cell line. Treatment of the human metastatic breast carcinoma cell line MT-2 with MDL28170 and 3-(4-iodophenyl)-2-mercapto-(Z)-2-propenoic acid (PD 150606), two calpain-selective inhibitors, completely abolished the TCDD-induced transactivation of AhR as assessed by transcription of CYP1A1 gene. Previous studies have established that after TCDD-induced transactivation, the AhR undergoes a massive depletion; we show here that selective calpain inhibitors can block this step, which suggests that the ligand-induced down-regulation of the AhR is calpain-dependent. The data presented support a major role for calpain in the AhR transformation, transactivation, and subsequent down-regulation, and provide a possible explanation for many of the reported phenomena of ligand-independent activation of AhR.
Received for publication June 5, 2006.
Accepted for publication August 4, 2006.
Address correspondence to: Dr. Sakina Eltom, 1005 Dr. D.B. Todd Blvd, Nashville, TN 37208, Tel/Fax: (615) 327-5713, seltom{at}mmc.edu
This article has been cited by other articles:
![]() |
C. J. MacDonald, R. Y. S. Cheng, D. D. Roberts, D. A. Wink, and G. C. Yeh Modulation of Carcinogen Metabolism by Nitric Oxide-Aspirin 2 Is Associated with Suppression of DNA Damage and DNA Adduct Formation J. Biol. Chem., August 14, 2009; 284(33): 22099 - 22107. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Kim, Y.-J. Shim, Y.-J. Shin, D. Sul, E. Lee, and B.-H. Min 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) Induces Calcium Influx Through T-type Calcium Channel and Enhances Lysosomal Exocytosis and Insulin Secretion in INS-1 Cells International Journal of Toxicology, May 1, 2009; 28(3): 151 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Monteiro, D. Gilot, E. Le Ferrec, C. Rauch, D. Lagadic-Gossmann, and O. Fardel Dioxin-Mediated Up-Regulation of Aryl Hydrocarbon Receptor Target Genes Is Dependent on the Calcium/Calmodulin/CaMKI{alpha} Pathway Mol. Pharmacol., March 1, 2008; 73(3): 769 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Pollenz Comments on "Calpain Mediates the Dioxin-Induced Activation and Down-Regulation of the Aryl Hydrocarbon Receptor" Mol. Pharmacol., January 1, 2007; 71(1): 384 - 385. [Full Text] [PDF] |
||||
![]() |
S. E. Eltom and Y. Dale Response to Comments on "Calpain Mediates the Dioxin-Induced Activation and Down-Regulation of the Aryl Hydrocarbon Receptor" Mol. Pharmacol., January 1, 2007; 71(1): 386 - 387. [Full Text] [PDF] |
||||